Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers

Clinical trial NCT04196465 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04196465
Sponsor: Asan Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Subjects With Resectable and Localized Gastric Cancer Subjects With Resectable Esophageal Cancer or Liver Cancer Subjects With Resectable Liver Cancer

Start date: 2019-09-09
Primary completion: 2026-09-09
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.